Liver Disease pp 117-140 | Cite as

Asymptomatic, Nonmalignant Liver Masses: A Radiologist’s Approach

  • Raj Mohan PaspulatiEmail author


Asymptomatic liver mass lesions are incidental findings on imaging performed for non-hepatic indications. Advances in radiological imaging and easy availability have led to more frequent use of imaging, resulting in detection of asymptomatic liver lesions. In addition, screening protocols such as CT colonography and cardiac and lung cancer CT screening which include the upper abdomen have resulted in the detection of more incidental liver lesions. These incidental liver lesions have not only created unnecessary concern and apprehension for the patients but also management dilemmas for the clinician. In this chapter, we describe a case of a patient with an incidental liver mass. We briefly discuss the epidemiology and clinical features and focus on the radiologic characteristics of some of the more commonly seen liver benign lesions.


Hepatic hemangiomas Focal nodular hyperplasia Hepatocellular adenomas Hepatic cysts Ultrasound CT MRI Nuclear medicine scans 

Selected References

  1. 1.
    Nguyen XV, Davies L, Eastwood JD, Hoang JK. Extrapulmonary findings and malignancies in participants screened with chest CT in the National Lung Screening Trial. J Am Coll Radiol. 2017;14(3):324–30.CrossRefGoogle Scholar
  2. 2.
    Kaltenbach TE, Engler P, Kratzer W, Oeztuerk S, Seufferlein T, Haenle MM, Graeter T. Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients. Abdom Radiol. 2016;41(1):25–32.CrossRefGoogle Scholar
  3. 3.
    Semelka RC, Sofka CM. Hepatic hemangiomas. Magn Reson Imaging N Am. 1997;5:241–53.Google Scholar
  4. 4.
    Golli M, Mathieu D, Anglade MC, Cherqui D, Vasile N, Rahmouni A. Focal nodular hyperplasia of the liver: value of color Doppler US in association with MR imaging. Radiology. 1993;187(1):113–7.CrossRefGoogle Scholar
  5. 5.
    Grazioli L, Morana G, Kirchin MA, Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine–enhanced MR imaging: prospective study. Radiology. 2005;236(1):166–77.CrossRefGoogle Scholar
  6. 6.
    Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S, Wendum D, Chiche L, Fabre M, Mellottee L, Laurent C, Partensky C, Castaing D, Zafrani ES, Laurent-Puig P, Balabaud C, Bioulac-Sage P. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43(3):515–24.CrossRefGoogle Scholar
  7. 7.
    Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Dig Surg. 2010;27(1):39–45.CrossRefGoogle Scholar
  8. 8.
    Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 2008;48(3):808–18.CrossRefGoogle Scholar
  9. 9.
    Mavilia MG, Pakala T, Molina M, Wu GY. Differentiating cystic liver lesions: a review of imaging modalities, diagnosis and management. J Clin Transl Hepatol. 2018;6(2):208–16.CrossRefGoogle Scholar
  10. 10.
    Lantinga MA, Gevers TJG, Drenth JPH. Evaluation of hepatic cystic lesions. World J Gastroenterol. 2013;19(23):3543–54.CrossRefGoogle Scholar
  11. 11.
    Gore RM, et al. Management of incidental liver lesions on CT: a white paper of the ACR incidental findings committee. J Am Coll Radiol. 2017;14(11):1429–37.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Digestive Health Institute, Head of GI and GYN Radiology, Division of Abdominal Imaging, Department of Radiology, University Hospitals, Case Western Reserve UniversityClevelandUSA

Personalised recommendations